Antonio Giordano to Furans
This is a "connection" page, showing publications Antonio Giordano has written about Furans.
Connection Strength
0.812
-
Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide. Int J Oncol. 2019 Jun; 54(6):2189-2199.
Score: 0.631
-
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial. Int J Med Sci. 2021; 18(10):2245-2250.
Score: 0.181